CNMD
CONMED Corporation
Healthcare · Medical Devices · NYQ
$35.16
Data: 2026-05-28
✓ ETHICAL PASS

Unknown MOAT
HIGH
Data Confidence: 100.0%
Key Metrics

How this company measures up on the fundamentals that matter

Market Cap
$1.1B
Total market value of the company
20.05
Premium valuation
7.32
Based on estimated future earnings — lower means cheaper
Rev Growth
-1.3%
Year-over-year revenue change
Profit Margin
4.0%
How much profit the company keeps from each dollar of revenue
5.5%
Return on equity — how efficiently it uses shareholder money
Analyst Target
$40.00
+14% from current price — median analyst estimate
Recommendation
HOLD
Consensus view from 5 analysts covering this stock
About CONMED Corporation

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries. It also provides battery-powered, autoclavable, large, and small bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under the Hall surgical brand name. In addition, the company offers general surgery products, such as clinical insufflation systems under the AirSeal brand; smoke removal devices under the Buffalo Filter brand; endomechanical products, including the Anchor1 line of tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors, used in minimally invasive surgeries; and electrosurgical solution comprise monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems, and other accessories. Further, it provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products to treat diseases of dilation, hemostasis, biliary, stricture management, infection prevention, and patient monitoring include ECG electrodes, EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.

https://www.conmed.com

Country: United States Employees: 3,900 Industry: Medical Devices
Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity
PASS
Core business does not involve prohibited activities
Debt Ratio
0.0% N/A
Debt must be below 33% of total assets
Cash Ratio
0.0% N/A
Interest-bearing cash below 33% of assets
Receivables
0.0% N/A
Receivables below 49% of assets
Revenue Purity
0.0% PASS
Non-compliant revenue below 5% — any excess requires purification
Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

MARKDOWN
Price trending down — defensive positioning
-0.686
Returns do not compensate for the risk — negative edge
-0.0590
No positive edge detected — the data suggests staying out
-0.539
Drawdown risk outweighs the returns — higher risk profile
Annual Return
-30.3%
Historical annualised return based on price data
-56.2%
Largest peak-to-trough decline — the worst it has been
SIDEWAYS
Price consolidating — no clear directional bias
Days in State
2
How long the current regime has persisted — longer means more stable
Market Data

Trading characteristics and market positioning

0.94
Less volatile than the market — more defensive
52W High
$60.35
42% below the year high
52W Low
$33.21
6% above the year low
Avg Volume
430,196
Average daily shares traded — higher means easier to buy and sell
5.2
Days it would take all short sellers to cover — higher means more crowded
Short % Float
9.0%
Moderate short interest
225.0%
Annual dividend as a percentage of the share price
$1.77
Earnings per share over the last 12 months
Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

84.59
Heavy leverage — higher financial risk if revenues decline
2.29
Strong balance sheet — comfortably covers short-term obligations
Quick Ratio
0.90
Like current ratio but excludes inventory — stricter test
Gross Margin
54.1%
Revenue left after cost of goods — higher means pricing power
Operating Margin
10.0%
Profit from core operations before interest and tax
$126M
Positive — the business generates more cash than it spends
Revenue (TTM)
$1.4B
Total revenue over the last 12 months
Net Income
$55M
Profitable — the bottom line is positive
Analyst Coverage
Analysts
5
Target High
$40.00
Target Median
$40.00
Target Low
$39.00
Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Discover More
Alpha Insights Market Intelligence Titan Watch Ethical Screener Insider Intelligence Track Record Ethical Finance Zakat Calculator Iran Oil Tracker Foundry (292 articles) Indicators Join Free →

Get our weekly market brief free.